We are live on
!
Find out more
US Bancorp Portfolio holdings
AUM
$82.4B
1-Year Est. Return
19.69%
This Fund
S&P 500
This Quarter
Est. Return
+8.01%
1 Year Est. Return
+19.69%
3 Year Est. Return
+59.6%
5 Year Est. Return
+69.89%
10 Year Est. Return
+246.63%
AUM
$39.1B
AUM Growth
+$2.42B
(+6.6%)
Cap. Flow
-$248M
Cap. Flow
% of AUM
-0.63%
Top 10 Holdings %
Top 10 Hldgs %
22.64%
Holding
3,845
New
218
Increased
1,110
Reduced
1,483
Closed
148
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell Mid-Cap ETF
IWR
|
+$45.6M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$40.7M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$38.8M |
| 4 |
iShares S&P 500 Value ETF
IVE
|
+$35.5M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$34.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$80.2M |
| 2 |
Copart
CPRT
|
+$55.9M |
| 3 |
US Bancorp
USB
|
+$47.8M |
| 4 |
IBDK
iShares iBonds Dec 2019 Term Corporate ETF
IBDK
|
+$25.8M |
| 5 |
iShares Floating Rate Bond ETF
FLOT
|
+$17.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.27% |
| 2 | Financials | 10.78% |
| 3 | Industrials | 9.91% |
| 4 | Healthcare | 9.19% |
| 5 | Consumer Staples | 6.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
iPath Select MLP ETN
ATMP
$647M
| $267K | ﹤0.01% |
15,000
| – | – |
|
1677
Preferred Bank
PFBC
$1.22B
| $267K | ﹤0.01% |
4,441
+1,088
| +32% | +$59.7K |
|
1678
Vanguard Total World Stock ETF
VT
$76.3B
| $267K | ﹤0.01% |
3,292
+1,309
| +66% | +$102K |
|
1679
LeMaitre Vascular
LMAT
$2.18B
| $266K | ﹤0.01% |
7,400
+50
| +0.7% | +$1.73K |
|
1680
Televisa
TV
$1.45B
| $266K | ﹤0.01% |
22,716
+1,950
| +9% | +$21.6K |
|
|
TWTR
1681
DELISTED
Twitter, Inc.
TWTR
| $266K | ﹤0.01% |
8,315
-3,284
| -28% | -$108K |
|
1682
Bruker
BRKR
$9.2B
| $265K | ﹤0.01% |
5,210
+1,104
| +27% | +$52.6K |
|
1683
Nuveen California Quality Municipal Income Fund
NAC
$1.83B
| $265K | ﹤0.01% |
17,781
| – | – |
|
1684
CF Industries
CF
$19.2B
| $264K | ﹤0.01% |
5,527
-7,264
| -57% | -$340K |
|
|
HBI
1685
DELISTED
Hanesbrands
HBI
| $264K | ﹤0.01% |
17,831
-541
| -3% | -$8.22K |
|
1686
Ryder
R
$10.3B
| $264K | ﹤0.01% |
4,870
-1,801
| -27% | -$93.7K |
|
1687
Invesco S&P 500 High Dividend Low Volatility ETF
SPHD
$3.36B
| $264K | ﹤0.01% |
6,001
| – | – |
|
1688
TherapeuticsMD
TXMD
$23.8M
| $264K | ﹤0.01% |
2,182
| – | – |
|
|
NS
1689
DELISTED
NuStar Energy L.P.
NS
| $264K | ﹤0.01% |
10,172
-9,522
| -48% | -$265K |
|
1690
CryoPort
CYRX
$775M
| $263K | ﹤0.01% |
15,957
| – | – |
|
1691
Methanex
MEOH
$4.32B
| $263K | ﹤0.01% |
6,819
-121
| -2% | -$4.54K |
|
1692
Gibraltar Industries
ROCK
$1.34B
| $263K | ﹤0.01% |
5,211
+1,607
| +45% | +$80.7K |
|
1693
Xerox
XRX
$337M
| $263K | ﹤0.01% |
7,130
-2,723
| -28% | -$95.2K |
|
1694
National Healthcare
NHC
$3.53B
| $262K | ﹤0.01% |
3,031
-3,515
| -54% | -$294K |
|
1695
Royce Value Trust
RVT
$2.21B
| $262K | ﹤0.01% |
17,753
| – | – |
|
1696
SiteOne Landscape Supply
SITE
$4.43B
| $262K | ﹤0.01% |
2,892
+53
| +2% | +$4.5K |
|
1697
UFP Technologies
UFPT
$1.84B
| $262K | ﹤0.01% |
5,290
| – | – |
|
|
TEN
1698
Tsakos Energy Navigation Ltd
TEN
$1.19B
| $262K | ﹤0.01% |
12,000
| – | – |
|
1699
Agnico Eagle Mines
AEM
$72.6B
| $261K | ﹤0.01% |
4,238
-1,331
| -24% | -$77.3K |
|
1700
Pacira BioSciences
PCRX
$1.02B
| $261K | ﹤0.01% |
5,756
+3,557
| +162% | +$151K |
|
Similar funds
US Bancorp's Q4 2019 Portfolio in Review
As of Q4 2019, US Bancorp held 3,845 positions worth $39.1B, up 6.6% from $36.7B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
US Bancorp's Q4 2019 filing shows 218 new, 1,110 increased, 1,483 reduced and 148 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 611,031 shares worth $1.84M. The largest sale was Celgene Corp, an estimated $80.2M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Industrials.
- US Bancorp's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 611,031 shares worth $1.84M.
- US Bancorp added most to iShares Russell Mid-Cap ETF in Q4 2019, an estimated $45.6M increase.
- US Bancorp's biggest Q4 2019 reduction was Copart, cutting an estimated $55.9M.
- US Bancorp fully exited Celgene Corp in Q4 2019, selling an estimated $80.2M.
- US Bancorp's ten largest holdings make up 23% of its $39.1B portfolio in Q4 2019.
- US Bancorp opened 218 new positions and closed 148 in Q4 2019.
- US Bancorp's portfolio value rose 6.6% quarter-over-quarter to $39.1B.
Based on US Bancorp's 13F filing for Q4 2019, filed 4 Feb 2020.